These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 12631625

  • 1. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines.
    Stearns ME, Wang M, Hu Y, Garcia FU, Rhim J.
    Clin Cancer Res; 2003 Mar; 9(3):1191-9. PubMed ID: 12631625
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
    Stearns ME, Kim G, Garcia F, Wang M.
    Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
    Udayakumar TS, Nagle RB, Bowden GT.
    Prostate; 2004 Jan 01; 58(1):66-75. PubMed ID: 14673954
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2000 May 01; 6(5):2104-19. PubMed ID: 10815938
    [Abstract] [Full Text] [Related]

  • 7. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
    Wang M, Fudge K, Rhim JS, Stearns ME.
    Oncol Res; 1996 May 01; 8(7-8):303-15. PubMed ID: 8938794
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
    Sehgal I, Thompson TC.
    Cancer Res; 1998 Oct 01; 58(19):4288-91. PubMed ID: 9766654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
    Yu M, Bowden ET, Sitlani J, Sato H, Seiki M, Mueller SC, Thompson EW.
    Cancer Res; 1997 Nov 15; 57(22):5028-32. PubMed ID: 9371497
    [Abstract] [Full Text] [Related]

  • 13. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P, He J, Axelrad TW, Bazan HE.
    Invest Ophthalmol Vis Sci; 2005 Feb 15; 46(2):487-96. PubMed ID: 15671273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.
    Polette M, Gilles C, Nawrocki-Raby B, Lohi J, Hunziker W, Foidart JM, Birembaut P.
    Cancer Res; 2005 Sep 01; 65(17):7691-8. PubMed ID: 16140936
    [Abstract] [Full Text] [Related]

  • 18. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells.
    Armstrong DA, Phelps LN, Vincenti MP.
    Mol Cancer Res; 2009 Sep 01; 7(9):1517-24. PubMed ID: 19723873
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.